Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Kraya

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Neurology|February 1, 2025
Serum chitotriosidase-1 (CHIT1) as candidate biomarker for mitochondriopathiesLaura Foerster, Leila Scholle, Tobias Mayer, et al.
The Lancet. Neurology|November 27, 2020
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trialMark Obermann, Steffen Nägel, Claudia Ose, et al.
Neurological Research and Practice|November 25, 2025
Teleneurology expertise in intensive care units across Germany - a nationwide surveyEyad Altarsha, Kristian Barlinn, Albrecht Günther, et al.
Der Nervenarzt|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Schmerz (Berlin, Germany)|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Brain : a Journal of Neurology|January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathyMarcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
The Journal of Clinical Investigation|February 20, 2018
TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutationsYouJin Lee, Per Harald Jonson, Jaakko Sarparanta, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Neurology|February 1, 2025
Serum chitotriosidase-1 (CHIT1) as candidate biomarker for mitochondriopathiesLaura Foerster, Leila Scholle, Tobias Mayer, et al.
The Lancet. Neurology|November 27, 2020
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trialMark Obermann, Steffen Nägel, Claudia Ose, et al.
Neurological Research and Practice|November 25, 2025
Teleneurology expertise in intensive care units across Germany - a nationwide surveyEyad Altarsha, Kristian Barlinn, Albrecht Günther, et al.
Der Nervenarzt|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Schmerz (Berlin, Germany)|October 26, 2022
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]Gudrun Goßrau, Stefanie Förderreuther, Ruth Ruscheweyh, et al.
Brain : a Journal of Neurology|January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathyMarcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
The Journal of Clinical Investigation|February 20, 2018
TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutationsYouJin Lee, Per Harald Jonson, Jaakko Sarparanta, et al.
Pageof 5